These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 30352896)

  • 21. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
    Heinemann L; Freckmann G; Müller-Wieland D; Kellerer M
    J Diabetes Sci Technol; 2020 Sep; 14(5):922-927. PubMed ID: 31675907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
    Yapanis M; James S; Craig ME; O'Neal D; Ekinci EI
    J Clin Endocrinol Metab; 2022 May; 107(6):e2221-e2236. PubMed ID: 35094087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
    Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
    Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
    Lu J; Ma X; Zhou J; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W
    Diabetes Care; 2018 Nov; 41(11):2370-2376. PubMed ID: 30201847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study.
    Lu J; Ma X; Zhang L; Mo Y; Lu W; Zhu W; Bao Y; Jia W; Zhou J
    Diabetes Res Clin Pract; 2020 Mar; 161():108032. PubMed ID: 32006646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring.
    Shen Y; Fan X; Zhang L; Wang Y; Li C; Lu J; Zha B; Wu Y; Chen X; Zhou J; Jia W
    Diabetes Care; 2021 Apr; 44(4):976-982. PubMed ID: 33574126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients.
    Wang Y; Lu J; Shen Y; Ni J; Zhang L; Lu W; Zhu W; Bao Y; Zhou J
    J Diabetes Investig; 2022 Sep; 13(9):1543-1550. PubMed ID: 35435323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research progress in the application of time in range: more than a percentage.
    Wan J; Lu J; Li C; Ma X; Zhou J
    Chin Med J (Engl); 2023 Mar; 136(5):522-527. PubMed ID: 36939244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of hemoglobin A1c time in range with risk for diabetes complications.
    Mohr DC; Zhang L; Prentice JC; Nelson RE; Li D; Pleasants E; Conlin PR
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35820708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
    Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
    Engelgau MM; Thompson TJ; Herman WH; Boyle JP; Aubert RE; Kenny SJ; Badran A; Sous ES; Ali MA
    Diabetes Care; 1997 May; 20(5):785-91. PubMed ID: 9135943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion.
    Lanspa MJ; Krinsley JS; Hersh AM; Wilson EL; Holmen JR; Orme JF; Morris AH; Hirshberg EL
    Chest; 2019 Nov; 156(5):878-886. PubMed ID: 31201784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set.
    Beck RW; Bergenstal RM; Riddlesworth TD; Kollman C
    Diabetes Technol Ther; 2019 Jan; 21(1):1-5. PubMed ID: 30575408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of time in blood glucose range with outcomes following cardiac surgery.
    Omar AS; Salama A; Allam M; Elgohary Y; Mohammed S; Tuli AK; Singh R
    BMC Anesthesiol; 2015; 15(1):14. PubMed ID: 25670921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
    Fabris C; Heinemann L; Beck R; Cobelli C; Kovatchev B
    Diabetes Technol Ther; 2020 Jul; 22(7):501-508. PubMed ID: 32459124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.